Andrie, K.M.; Musci, R.V.; Walsh, M.A.; Bork, S.; Valenti, Z.J.; Sanford, J.; Campbell, M.; F. Afzali, L.; Afzali, M.F.; Hamilton, K.L.;
et al. Three-Month Administration of PB125 Modifies Histopathology, Redox Homeostasis, and Mobility in the Hartley Guinea Pig Model of Primary Osteoarthritis. Antioxidants 2026, 15, 212.
https://doi.org/10.3390/antiox15020212
AMA Style
Andrie KM, Musci RV, Walsh MA, Bork S, Valenti ZJ, Sanford J, Campbell M, F. Afzali L, Afzali MF, Hamilton KL,
et al. Three-Month Administration of PB125 Modifies Histopathology, Redox Homeostasis, and Mobility in the Hartley Guinea Pig Model of Primary Osteoarthritis. Antioxidants. 2026; 15(2):212.
https://doi.org/10.3390/antiox15020212
Chicago/Turabian Style
Andrie, Kendra M., Robert V. Musci, Maureen A. Walsh, Sydney Bork, Zachary J. Valenti, Joseph Sanford, Margaret Campbell, Leila F. Afzali, Maryam F. Afzali, Karyn L. Hamilton,
and et al. 2026. "Three-Month Administration of PB125 Modifies Histopathology, Redox Homeostasis, and Mobility in the Hartley Guinea Pig Model of Primary Osteoarthritis" Antioxidants 15, no. 2: 212.
https://doi.org/10.3390/antiox15020212
APA Style
Andrie, K. M., Musci, R. V., Walsh, M. A., Bork, S., Valenti, Z. J., Sanford, J., Campbell, M., F. Afzali, L., Afzali, M. F., Hamilton, K. L., & Santangelo, K. S.
(2026). Three-Month Administration of PB125 Modifies Histopathology, Redox Homeostasis, and Mobility in the Hartley Guinea Pig Model of Primary Osteoarthritis. Antioxidants, 15(2), 212.
https://doi.org/10.3390/antiox15020212